Document is current
Any future updates will be listed below
-
Authors
Ross, Laura https://orcid.org/0000-0003-4636-729X
Baron, Murray https://orcid.org/0000-0002-0435-6165
Nikpour, Mandana
-
Funding
Funding for this research was provided by:
Royal Australasian College of Physicians
National Health and Medical Research Council
University of Melbourne
- License Information
-
More Information
Article History
Accepted: 6 February 2025
First Online: 15 February 2025
Declarations
:
: All co-authors were primary investigators in the development of the Scleroderma Clinical Trials Consortium Activity Index. LR: Research grants from Scleroderma Clinical Trials Consortium MB: Research grants from Scleroderma Clinical Trials Consortium MN: Research grants from Scleroderma Clinical Trials Consortium, Boehringer Ingelheim, Janssen. Consultancies and honoraria from AstraZeneca, Boehringer Ingelheim, GSK and Janssen.MB was a co-investigator in the development of the 2017 EUSTAR Activity Index.
